Historical Valuation
Rapid Micro Biosystems Inc (RPID) is now in the Fair zone, suggesting that its current forward PS ratio of 3.51 is considered Fairly compared with the five-year average of -3.33. The fair price of Rapid Micro Biosystems Inc (RPID) is between 2.99 to 4.10 according to relative valuation methord.
Relative Value
Fair Zone
2.99-4.10
Current Price：3.25
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Rapid Micro Biosystems Inc (RPID) has a current Price-to-Book (P/B) ratio of 3.14. Compared to its 3-year average P/B ratio of 0.99 , the current P/B ratio is approximately 217.31% higher. Relative to its 5-year average P/B ratio of 1.02, the current P/B ratio is about 206.96% higher. Rapid Micro Biosystems Inc (RPID) has a Forward Free Cash Flow (FCF) yield of approximately -27.72%. Compared to its 3-year average FCF yield of -95.12%, the current FCF yield is approximately -70.85% lower. Relative to its 5-year average FCF yield of -74.10% , the current FCF yield is about -62.59% lower.
P/B
Median3y
0.99
Median5y
1.02
FCF Yield
Median3y
-95.12
Median5y
-74.10
Competitors Valuation Multiple
AI Analysis for RPID
The average P/S ratio for RPID competitors is 3.86, providing a benchmark for relative valuation. Rapid Micro Biosystems Inc Corp (RPID.O) exhibits a P/S ratio of 3.51, which is -8.98% above the industry average. Given its robust revenue growth of 3.08%, this premium appears unsustainable.
Performance Decomposition
AI Analysis for RPID
1Y
3Y
5Y
Market capitalization of RPID increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of RPID in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is RPID currently overvalued or undervalued?
Rapid Micro Biosystems Inc (RPID) is now in the Fair zone, suggesting that its current forward PS ratio of 3.51 is considered Fairly compared with the five-year average of -3.33. The fair price of Rapid Micro Biosystems Inc (RPID) is between 2.99 to 4.10 according to relative valuation methord.
What is Rapid Micro Biosystems Inc (RPID) fair value?
RPID's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Rapid Micro Biosystems Inc (RPID) is between 2.99 to 4.10 according to relative valuation methord.
How does RPID's valuation metrics compare to the industry average?
The average P/S ratio for RPID's competitors is 3.86, providing a benchmark for relative valuation. Rapid Micro Biosystems Inc Corp (RPID) exhibits a P/S ratio of 3.51, which is -8.98% above the industry average. Given its robust revenue growth of 3.08%, this premium appears unsustainable.
What is the current P/B ratio for Rapid Micro Biosystems Inc (RPID) as of Jan 09 2026?
As of Jan 09 2026, Rapid Micro Biosystems Inc (RPID) has a P/B ratio of 3.14. This indicates that the market values RPID at 3.14 times its book value.
What is the current FCF Yield for Rapid Micro Biosystems Inc (RPID) as of Jan 09 2026?
As of Jan 09 2026, Rapid Micro Biosystems Inc (RPID) has a FCF Yield of -27.72%. This means that for every dollar of Rapid Micro Biosystems Inc’s market capitalization, the company generates -27.72 cents in free cash flow.
What is the current Forward P/E ratio for Rapid Micro Biosystems Inc (RPID) as of Jan 09 2026?
As of Jan 09 2026, Rapid Micro Biosystems Inc (RPID) has a Forward P/E ratio of -3.69. This means the market is willing to pay $-3.69 for every dollar of Rapid Micro Biosystems Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Rapid Micro Biosystems Inc (RPID) as of Jan 09 2026?
As of Jan 09 2026, Rapid Micro Biosystems Inc (RPID) has a Forward P/S ratio of 3.51. This means the market is valuing RPID at $3.51 for every dollar of expected revenue over the next 12 months.